Bharat Parenterals Concludes EGM for Preferential Issue and Investment Limits Approval
Bharat Parenterals Ltd 路 Extra Ordinary General Meeting 路 23 Oct 2026, 8:54 pm
Bharat Parenterals Concludes EGM for Preferential Issue and Investment Limits Approval Bharat Parenterals Limited conducted its Extraordinary General Meeting on 23rd Oct'26 via video conferencing to seek shareholder approval for two special resolutions. The key proposals presented included the issuance of equity shares on a preferential basis for fundraising and investment in subsidiaries, alongside approval for making investments, extending loans, and providing guarantees in excess of the limits specified under Section 186(2) of the Companies Act, 2013. Voting results will be declared and published on the company's website within two working days.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
